KORU Medical Systems Inc (NAS:KRMD)

Q4 2025 KORU Medical Systems Inc Earnings Call Transcript

Mar 12, 2026 / 08:30 PM GMT

Release Date Price: $4.31 (-4.43%)

Transcript 10-K8-K

Key Points

Positve

KORU Medical Systems Inc (KRMD) achieved a 22% increase in full-year revenue, reaching $41.1 million, marking consistent growth.
The company received EU MDR certification for the Freedom 60 with prefilled syringe compatibility, enhancing its European market potential.
KORU Medical Systems Inc (KRMD) expanded its international core business by 71% year-over-year, driven by new patient starts and increased market penetration.
The company achieved positive cash flow from operations and ended the year with $8.9 million in cash, indicating financial stability.
KORU Medical Systems Inc (KRMD) announced two new pharma collaborations, expanding its development pipeline into new therapeutic areas.

Negative

The PST business decreased by 30% year-over-year due to the timing of contract milestones, reflecting variability in revenue recognition.
Gross margin decreased by 30 basis points in Q4 due to higher material costs and tariffs, impacting profitability.
The company faces geopolitical risks, particularly in the Middle East, which could affect future revenue guidance.
There is uncertainty regarding the timing of new drug clearances and OUS prefill conversions, which could impact revenue projections.
The oncology market entry is still in early stages, with limited immediate revenue contribution expected.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

KRMD.OQ - KORU Medical Systems Inc
Q4 2025 KORU Medical Systems Inc Earnings Call
Mar 12, 2026 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Greetings and welcome to the Ko Medical System's 4th quarter 2025 earnings call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. If anyone should require operator assistance, please press 0 on your telephone keypad. As a reminder, this conference is being recorded.

It is now my pleasure to introduce Louisa Smith, Investor relations. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, operator, and good afternoon, everyone. Joining me on the call today are Linda

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.